Biotech Business - June 23, 2026
CHOSA Oncology establishes US presence in Boston
CHOSA Oncology has established a business presence in Boston, Massachusetts, marking an important strategic step in the company's US commercialization for Platin-DRP.
Agreement - June 22, 2026
BioArctic and Lilly sign research and collaboration agreement
The company has entered into the agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed Lilly drug candidate in neurodegeneration.
Biotech Business - June 18, 2026
Medivir has completed a directed share issue of approx SEK 140 million
The Directed Share Issue was oversubscribed and included both new and existing investors, including Cicero Fonder, Storebrand Sverige Plus and Storebrand Sverige Småbolag Plus as well as Hallberg Management AB, Carl Bennet AB, LINC AB, and Nordea Småbolagsfond Norden.
Biotech Business - June 17, 2026
Alvotech announces USD 152 million share offering
Alvotech has announced the pricing of its previously announced underwritten public offering of 22,666,667 of its ordinary shares at an offering price of USD 3.75 per share.
Biotech Business - June 16, 2026
CEPI extends support for Abera’s development of the BERA vaccine platform
Abera Bioscience has announces that CEPI (Coalition for Epidemic Preparedness Innovations) has decided to extend the ongoing project supporting the development of Abera’s BERA vaccine platform and the company’s innovative influenza vaccine candidate.
Biotech Business - June 16, 2026
Aplagon announces EUR 5 million in financing
Aplagon has announced the close of a EUR 4.8 million (approx. USD 5.6 million) financing round to support its expansion into a new Phase 2 clinical programme in arteriovenous fistula (AVF) maturation failure in end stage kidney disease.
